Enliven Therapeutics
ELVN
#5396
Rank
ยฃ0.86 B
Marketcap
ยฃ17.62
Share price
-1.78%
Change (1 day)
50.69%
Change (1 year)

Enliven Therapeutics (ELVN) - Cash on Hand

Cash on Hand as of September 2024 : ยฃ0.23 Billion

According to Enliven Therapeutics's latest financial reports the company has ยฃ0.23 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Enliven Therapeutics - Cash on Hand chart (from 2021 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ0.19 B218.25%
2022-12-31ยฃ62.43 M-23.4%
2021-12-31ยฃ81.5 M-14.78%
2020-12-31ยฃ95.64 M